GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order

GlaxoSmithKline Pharmaceuticals made a disclosure in front of NSE and BSE that it has received an order from the West Bengal GST authorities demanding a penalty from the company.

GlaxoSmithKline Pharmaceuticals Receive GST Order

Shriya Mishra | Jun 27, 2025 |

GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order

GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order

Mumbai-based pharmaceutical company GlaxoSmithKline received an order on 24th June 2025, from the Commissioner, CGST & CX, Appeals-II, Kolkata, regarding Disallowance of transitional credit (TRAN 1 & TRAN 2 credit) for FY 2017–18.

The said authority has raised a total demand of Rs. 3,39,09,520 from the company.

The company made disclosure of the matter to the National Stock Exchange of India and BSE in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also stated that there is no impact on the financial operations of the organization, and it is evaluating the order and will take necessary steps regarding the same.

StudyCafe Membership

Join StudyCafe Membership. For More details about Membership Click Join Membership Button
Join Membership

In case of any Doubt regarding Membership you can mail us at [email protected]

Join Studycafe's WhatsApp Group or Telegram Channel for Latest Updates on Government Job, Sarkari Naukri, Private Jobs, Income Tax, GST, Companies Act, Judgements and CA, CS, ICWA, and MUCH MORE!"


Tags: GST, SEBI


Author Bio
My Recent Articles
Income Tax Dept Breaks Silence: No Mass Scrutiny for Small Taxpayers GST Return Filing to Get Tougher from July 1: Major Changes You Must Know Tax Trouble for Delhivery: Rs. 1.36 Cr Penalty Order from Income Tax Canada to remove Digital Services Tax to Restart Trade Talks with US IEC Update Deadline Ends Today: Don’t Miss Final Date to Avoid PenaltiesView All Posts
OSZAR »